2026/08/02
The 37th International Papillomavirus Conference (IPVC 2025), hosted by the International Papillomavirus Society (IPVS), was held in Bangkok, Thailand, from October 23–26, 2025, under the theme “Research Toward the Global Elimination of HPV-Related Diseases and Cancers.”
A Major Global Gathering in HPV Research
IPVC 2025 brought together 1,435 researchers, clinicians, and public health professionals from 104 countries and regions, reflecting the broad international engagement in HPV research, prevention, and disease control.
The conference received 1,208 abstracts, of which 1,084 were accepted. The scientific program included 99 oral presentations, 136 thematic poster presentations, and 814 poster presentations, covering a broad range of topics across basic science, clinical research, epidemiology, and public health.
Opening Ceremony Highlights
Conference Co-Chairs Anna R. Giuliano (USA) and Siriwan Tangjitgamol (Thailand), together with Organizing Committee Chair Aimeé Kreimer, welcomed participants and introduced the scientific program and key themes of the conference.
Keynote speaker Professor Praphan Phanuphak delivered a presentation entitled “Ending HPV: Lessons Learned from HIV.” Drawing on experience from HIV prevention and control, he highlighted the importance of public health education, HPV awareness, expanded screening and testing, improved vaccine accessibility, and collaboration among governments, researchers, healthcare professionals, and communities.
Anna R. Giuliano (USA), Co-Chair of IPVC 2025
Siriwan Tangjitgamol (Thailand), Co-Chair of IPVC 2025
Scientific Exchange Across Three Major Areas
The scientific program focused on three major areas: basic science, clinical science, and public health and epidemiology, highlighting recent advances in HPV research and prevention.
The Basic Science program covered HPV infection and replication, viral gene function and regulation—including E6, E7, E2, E1, and E5—host immune responses and immune evasion, DNA damage and repair, as well as research on preventive vaccines, therapeutic vaccines, and antiviral drug development.
The Clinical Science program focused on advances in screening, diagnosis, clinical management, and treatment of HPV infection and HPV-related diseases, including cervical cancer and other HPV-associated malignancies.
The Public Health and Epidemiology program addressed key priorities in cervical cancer elimination, including screening strategies, vaccination coverage, health equity, and prevention and control in resource-limited settings.
The conference also featured sessions for early-career researchers and discussions on HPV/HIV co-infection and related diseases, further promoting interdisciplinary and international collaboration.
Advancing the Global Effort Against HPV-Related Diseases
IPVC 2025 provided an important international platform for researchers, clinicians, and public health professionals to exchange scientific advances and perspectives on HPV-related diseases.
Through collaboration across basic research, clinical practice, epidemiology, and public health, the conference reinforced the global commitment to preventing HPV-related diseases and advancing efforts toward the elimination of cervical cancer.
